Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07290569
What this trial is testing

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Oruka Therapeutics, Inc. 160
Large-scale testing (Phase 3)Study completedNCT05637515
What this trial is testing

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque Psoriasis
Biocon Biologics Inc. 374
Testing effectiveness (Phase 2)Temporarily pausedNCT04121143
What this trial is testing

A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults

Who this might be right for
Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 120
Not applicableLooking for participantsNCT06701513
What this trial is testing

A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)

Who this might be right for
Psoriasis
Bristol-Myers Squibb 350
Large-scale testing (Phase 3)Study completedNCT00106834
What this trial is testing

The Safety and Efficacy of Infliximab in Patients With Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 378
Early research (Phase 1)Study completedNCT02993471
What this trial is testing

Ixekizumab in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 28
Post-approval studies (Phase 4)Not Yet RecruitingNCT07485764
What this trial is testing

Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients

Who this might be right for
PsoriasisPlaque PsoriasisModerate-to-severe Plaque Psoriasis+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 186
Large-scale testing (Phase 3)Study completedNCT02561806
What this trial is testing

Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 302
Large-scale testing (Phase 3)Ended earlyNCT00833053
What this trial is testing

Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 39
Large-scale testing (Phase 3)Study completedNCT04785326
What this trial is testing

Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Dong-A ST Co., Ltd. 598
Not applicableStudy completedNCT02305953
What this trial is testing

Cytokines and Vascular Inflammation in Psoriasis

Who this might be right for
Vascular InflammationPsoriasisCoronary Atherosclerosis
Innovaderm Research Inc. 96
Post-approval studies (Phase 4)Study completedNCT03739853
What this trial is testing

Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial

Who this might be right for
Psoriatic Arthritis
University of Oxford 192
Not applicableEnded earlyNCT07449234
What this trial is testing

Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag Ltd. 9
Post-approval studies (Phase 4)UnknownNCT01088165
What this trial is testing

The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis

Who this might be right for
PsoriasisCardiovascular DiseasesDiabetes Mellitus, Type 2
Medical University of Vienna 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT06875934
What this trial is testing

A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd 145
Testing effectiveness (Phase 2)UnknownNCT05604898
What this trial is testing

Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 139
Testing effectiveness (Phase 2)Looking for participantsNCT06231381
What this trial is testing

Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)

Who this might be right for
Generalized Pustular Psoriasis (GPP)
Shanghai Huaota Biopharmaceutical Co., Ltd. 33
Early research (Phase 1)WithdrawnNCT01260844
What this trial is testing

Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.

Who this might be right for
Moderate to Severe Plaque Psoriasis
Abbott 12
Large-scale testing (Phase 3)Study completedNCT06588738
What this trial is testing

A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

Who this might be right for
Plaque Psoriasis
Alumis Inc 862
Testing effectiveness (Phase 2)Study completedNCT02931838
What this trial is testing

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 268
Next Page